8-K

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):   October 8, 2010

MET-PRO CORPORATION
(Exact name of registrant as specified in its charter)

Pennsylvania	001-07763	23-1683282
(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation or organization)		Identification No.)

160 Cassell Road, P.O. Box 144
Harleysville, Pennsylvania	19438
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (215) 723-6751

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events

On October 8, 2010, Met-Pro Corporation completed its acquisition of substantially all of the assets of Bio-Reaction Industries, LLC, a company that researches, develops, and manufactures products that biologically digest volatile organic compounds created in various types of industries, pursuant to an Asset Purchase Agreement dated as of September 21, 2010. The assets of Bio-Reaction Industries, LLC that were sold and transferred to Met-Pro Corporation include, but are not limited to, the following: (i) raw materials, work-in-process and finished goods; (ii) tangible personal property such as office furniture and equipment; (iii) intangible rights and property such as goodwill and rights in and to the name “Bio-Reaction Industries, LLC”, product names, trade names, trademarks and patents; and (iv) information and data. As part of the transactions contemplated by the Purchase Agreement, Met-Pro Corporation did not assume any liabilities of Bio-Reaction Industries, LLC.

A copy of the press release dated October 12, 2010, reporting the asset purchase of Bio-Reaction Industries, LLC, is furnished herewith as Exhibit 99.1.

Item 9.01(d) Financial Statements and Exhibits

A copy of the press release dated October 12, 2010, reporting the asset purchase of Bio-Reaction Industries, LLC, is furnished herewith as Exhibit 99.1.

The information included in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:  October 12, 2010

MET-PRO CORPORATION

By: /s/ Gary J. Morgan

Gary J. Morgan,

Senior Vice President-Finance and

Chief Financial Officer

Exhibit Index

Exhibit	Description
99.1	Press release dated October 12, 2010

EX-99.1

Date:	October 12, 2010
For Release:	Immediate
Contact:	Investor Contact:
	Gary J. Morgan,	Joseph Hassett, SVP
	Senior Vice President of Finance, CFO	Gregory FCA Communications
	215-723-6751	610-228-2110

Met-Pro Corporation Acquires Patented Biological Technology

• Provides new global municipal and industrial market opportunities

• Strengthens Met-Pro’s “Total Air Solutions” value proposition

Harleysville, PA, October 12, 2010 – Raymond J. De Hont, Chairman and Chief Executive Officer of Met-Pro Corporation (NYSE:MPR), announced today that the Company has acquired substantially all of the assets including the patents and technology of Bio-Reaction Industries LLC (“BRI”), a pioneer in environmentally friendly air pollution control systems utilizing state-of-the-art biological technology to eliminate volatile organic compounds (VOCs), hazardous air pollutants (HAPs), and odors.

“The acquisition of these assets significantly enhances Met-Pro’s competitive position in both the municipal and industrial global markets by providing not only state-of-the-art biological technologies, but also a broad global reference base of satisfied customers,” stated De Hont. “BRI’s patented biological technology, which is a perfect complement to our Met-Pro Environmental Air Solutions’ thermal oxidizer and chemical scrubber technologies, strengthens our “Total Air Solutions” value proposition, allowing us to better address the increasingly more stringent environmental regulations and the global focus on greenhouse gas reduction. We believe our extensive relationships within the municipal market will enable us to quickly grow BRI’s municipal market share , while BRI’s relationships within a diverse base of industrial markets provides opportunities to introduce Met-Pro’s broad range of solutions to new markets.”

BRI’s bio-oxidation systems are the new standard in air pollution control technology, utilizing naturally existing microbes to biologically break down HAPs and VOCs. BRI offers a modular, reliable bio-oxidation solution that achieves the highest removal efficiency of VOCs for any air phase biological treatment system in the world. BRI’s innovative vapor-phase bio-technologies provide a cost effective way to comply with regulatory requirements, treating high volume, low concentration air streams and delivering dramatic energy savings for a wide range of applications, including municipalities, paints and coatings, wood products, building materials, and the chemical processing industry. BRI’s patented Bio-airSPHER ES enhance microbial activity and air contaminant digestion, effectively reducing carbon footprints and significantly cutting operating costs when compared with other less efficient technologies.

Terms of the transaction were not disclosed. It is expected that the acquisition will have no impact upon current year earnings but will be accretive to earnings in the Company’s fiscal year ending January 31, 2012.

About Bio-Reaction Industries LLC

Bio-Reaction Industries LLC, Tualatin, Oregon, designs and manufactures biological air pollution control systems that utilize microbes to digest industrial and municipal pollutants and eliminate odors.

BRI is a global leader in the emerging, energy efficient biofiltration industry with strategic partners established and operating in both Europe and Asia. Numerous research and development programs are in place as BRI continues to develop the next generation of biofiltration air control technologies.

BRI serves the wood products, paint and coating, chemical processing, municipal utility, food and beverage and automotive industries. Customers include Louisiana Pacific, Weyerhaeuser, Sherwin Williams, Bangor Naval Station, and municipalities such as Wilsonville, Oregon and Falmouth, Massachusetts. For more information, visit: http://www.bioreaction.com/home.

About Met-Pro

Met-Pro Corporation, with headquarters at 160 Cassell Road, Harleysville, Pennsylvania, is a leading niche-oriented global provider of product recovery, pollution control and fluid handling solutions. The Company’s diverse and synergistic solutions and products address the world’s growing need to meet more stringent emission regulations, reduce energy consumption and employ green technology. Through its global sales organization, internationally recognized brands, and operations in the United States, Canada, Europe and The People's Republic of China, Met-Pro’s solutions, products and systems are sold to a well-diversified cross-section of customers and markets around the world. For more information, please visi t www.met-pro.com.

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this news release, and other materials filed or to be filed with the Securities and Exchange Commission (as well as information included in oral or other written statements made or to be made by the Company), contain statements that are forward-looking. Such statements may relate to plans for future expansion, business development activities, capital spending, financing, the effects of regulation and competition, or anticipated sales or earnings results. Such information involves risks and uncertainties that could significantly affect results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of the Company. These r isks and uncertainties include, but are not limited to, those relating to, the cancellation or delay of purchase orders and shipments, product development activities, goodwill impairment, computer systems implementation, dependence on existing management, the continuation of effective cost and quality control measures, retention of customers, global economic and market conditions, and changes in federal or state laws.

Met-Pro common shares are traded on the New York Stock Exchange, symbol MPR.

To obtain an Annual Report or additional information on the Company, please call 215-723-6751 and ask for the Investor Relations Department, or visit the Company’s website at www.met-pro.com.